The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: calcium     Quarter: 2016Q3

Total Records: 603     Number of Pages: 31

DRUGNAME PT EventCount
CALCIUM LEVOFOLINATE TEVA Dysphonia 1
CALCIUM LEVOFOLINATE TEVA Mucosal inflammation 1
CALCIUM LEVOFOLINATE TEVA Palmar-plantar erythrodysaesthesia syndrome 1
CALCIUM LEVOFOLINATE TEVA Pneumonia klebsiella 1
CALCIUM LEVOFOLINATE TEVA Proteinuria 1
CALCIUM LEVOFOLINATE TEVA Rectal haemorrhage 1
CALCIUM W/VIT.D3 Acute kidney injury 1
CALCIUM W/VIT.D3 Anaemia 1
CALCIUM W/VIT.D3 Anion gap increased 1
CALCIUM W/VIT.D3 Asthenia 1
CALCIUM W/VIT.D3 Blood bicarbonate increased 1
CALCIUM W/VIT.D3 Blood creatinine increased 1
CALCIUM W/VIT.D3 Blood pH increased 1
CALCIUM W/VIT.D3 Blood urea increased 1
CALCIUM W/VIT.D3 C-reactive protein increased 1
CALCIUM W/VIT.D3 Calcium ionised increased 1
CALCIUM W/VIT.D3 Carbon dioxide increased 1
CALCIUM W/VIT.D3 Glomerular filtration rate decreased 1
CALCIUM W/VIT.D3 Hypercalcaemia 1
CALCIUM W/VIT.D3 Listless 1

Total Records: 603     Number of Pages: 31